To evaluate whether the P450 inhibition assay can be used in diagnosing PD, we subjected the sera from patients with Alzheimer’s disease (AD) and type 2 diabetes (T2D) to the assay. Here, CYP2B6 is linked to early-onset autosomal dominant Alzheimer disease.